nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Ticagrelor—coronary artery disease	0.0567	0.146	CbGbCtD
Alfuzosin—CYP3A4—Fenofibrate—coronary artery disease	0.0506	0.13	CbGbCtD
Alfuzosin—KCNH2—purkinje fiber—coronary artery disease	0.045	0.558	CbGeAlD
Alfuzosin—CYP3A4—Gemfibrozil—coronary artery disease	0.0404	0.104	CbGbCtD
Alfuzosin—CYP3A4—Clopidogrel—coronary artery disease	0.035	0.0905	CbGbCtD
Alfuzosin—CYP3A4—Eplerenone—coronary artery disease	0.0326	0.0841	CbGbCtD
Alfuzosin—CYP3A4—Enalapril—coronary artery disease	0.029	0.075	CbGbCtD
Alfuzosin—KCNH2—endocardium—coronary artery disease	0.0232	0.287	CbGeAlD
Alfuzosin—CYP3A4—Ezetimibe—coronary artery disease	0.0226	0.0583	CbGbCtD
Alfuzosin—CYP3A4—Rosuvastatin—coronary artery disease	0.0226	0.0583	CbGbCtD
Alfuzosin—CYP3A4—Simvastatin—coronary artery disease	0.021	0.0542	CbGbCtD
Alfuzosin—CYP3A4—Lovastatin—coronary artery disease	0.0205	0.053	CbGbCtD
Alfuzosin—CYP3A4—Pravastatin—coronary artery disease	0.0205	0.053	CbGbCtD
Alfuzosin—CYP3A4—Atorvastatin—coronary artery disease	0.0187	0.0483	CbGbCtD
Alfuzosin—CYP3A4—Losartan—coronary artery disease	0.0171	0.0442	CbGbCtD
Alfuzosin—Prazosin—SLC22A3—coronary artery disease	0.00237	0.701	CrCbGaD
Alfuzosin—KCNH2—cardiac ventricle—coronary artery disease	0.00195	0.0242	CbGeAlD
Alfuzosin—KCNH2—myocardium—coronary artery disease	0.00183	0.0227	CbGeAlD
Alfuzosin—ADRA1A—heart—coronary artery disease	0.00133	0.0164	CbGeAlD
Alfuzosin—KCNH2—heart—coronary artery disease	0.00128	0.0159	CbGeAlD
Alfuzosin—ADRA1A—cardiovascular system—coronary artery disease	0.00125	0.0155	CbGeAlD
Alfuzosin—KCNH2—cardiovascular system—coronary artery disease	0.00121	0.015	CbGeAlD
Alfuzosin—KCNH2—cardiac atrium—coronary artery disease	0.00109	0.0136	CbGeAlD
Alfuzosin—Doxazosin—CYP2C19—coronary artery disease	0.00101	0.3	CrCbGaD
Alfuzosin—ADRA1A—blood—coronary artery disease	0.000989	0.0123	CbGeAlD
Alfuzosin—KCNH2—blood—coronary artery disease	0.000955	0.0118	CbGeAlD
Alfuzosin—CYP3A4—blood—coronary artery disease	0.000592	0.00734	CbGeAlD
Alfuzosin—Chest pain—Ramipril—coronary artery disease	0.000168	0.000439	CcSEcCtD
Alfuzosin—Fatigue—Furosemide—coronary artery disease	0.000168	0.000439	CcSEcCtD
Alfuzosin—Abdominal pain—Telmisartan—coronary artery disease	0.000167	0.000438	CcSEcCtD
Alfuzosin—Vomiting—Lovastatin—coronary artery disease	0.000167	0.000437	CcSEcCtD
Alfuzosin—Somnolence—Losartan—coronary artery disease	0.000167	0.000436	CcSEcCtD
Alfuzosin—Dizziness—Eplerenone—coronary artery disease	0.000167	0.000436	CcSEcCtD
Alfuzosin—Rash—Clopidogrel—coronary artery disease	0.000167	0.000436	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000167	0.000436	CcSEcCtD
Alfuzosin—Dermatitis—Clopidogrel—coronary artery disease	0.000167	0.000436	CcSEcCtD
Alfuzosin—Asthenia—Valsartan—coronary artery disease	0.000166	0.000435	CcSEcCtD
Alfuzosin—Pain—Furosemide—coronary artery disease	0.000166	0.000435	CcSEcCtD
Alfuzosin—Constipation—Furosemide—coronary artery disease	0.000166	0.000435	CcSEcCtD
Alfuzosin—Ill-defined disorder—Lisinopril—coronary artery disease	0.000166	0.000434	CcSEcCtD
Alfuzosin—Discomfort—Ramipril—coronary artery disease	0.000166	0.000434	CcSEcCtD
Alfuzosin—Asthenia—Olmesartan—coronary artery disease	0.000166	0.000433	CcSEcCtD
Alfuzosin—Headache—Clopidogrel—coronary artery disease	0.000166	0.000433	CcSEcCtD
Alfuzosin—Rash—Lovastatin—coronary artery disease	0.000166	0.000433	CcSEcCtD
Alfuzosin—Dermatitis—Lovastatin—coronary artery disease	0.000165	0.000433	CcSEcCtD
Alfuzosin—Dyspepsia—Losartan—coronary artery disease	0.000165	0.000432	CcSEcCtD
Alfuzosin—Feeling abnormal—Perindopril—coronary artery disease	0.000165	0.000431	CcSEcCtD
Alfuzosin—Headache—Lovastatin—coronary artery disease	0.000165	0.00043	CcSEcCtD
Alfuzosin—Pruritus—Valsartan—coronary artery disease	0.000164	0.000429	CcSEcCtD
Alfuzosin—Dry mouth—Ramipril—coronary artery disease	0.000164	0.000429	CcSEcCtD
Alfuzosin—Chest pain—Timolol—coronary artery disease	0.000164	0.000429	CcSEcCtD
Alfuzosin—Arthralgia—Timolol—coronary artery disease	0.000164	0.000429	CcSEcCtD
Alfuzosin—Vomiting—Ezetimibe—coronary artery disease	0.000164	0.000428	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000164	0.000428	CcSEcCtD
Alfuzosin—Angioedema—Lisinopril—coronary artery disease	0.000163	0.000427	CcSEcCtD
Alfuzosin—Pruritus—Olmesartan—coronary artery disease	0.000163	0.000427	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000163	0.000426	CcSEcCtD
Alfuzosin—Abdominal pain—Captopril—coronary artery disease	0.000163	0.000426	CcSEcCtD
Alfuzosin—Dizziness—Simvastatin—coronary artery disease	0.000162	0.000425	CcSEcCtD
Alfuzosin—Rash—Ezetimibe—coronary artery disease	0.000162	0.000425	CcSEcCtD
Alfuzosin—Dermatitis—Ezetimibe—coronary artery disease	0.000162	0.000424	CcSEcCtD
Alfuzosin—Discomfort—Timolol—coronary artery disease	0.000162	0.000424	CcSEcCtD
Alfuzosin—Asthenia—Niacin—coronary artery disease	0.000162	0.000423	CcSEcCtD
Alfuzosin—Fatigue—Losartan—coronary artery disease	0.000162	0.000423	CcSEcCtD
Alfuzosin—Headache—Ezetimibe—coronary artery disease	0.000161	0.000422	CcSEcCtD
Alfuzosin—Malaise—Lisinopril—coronary artery disease	0.000161	0.000422	CcSEcCtD
Alfuzosin—Oedema—Ramipril—coronary artery disease	0.000161	0.000421	CcSEcCtD
Alfuzosin—Vertigo—Lisinopril—coronary artery disease	0.000161	0.00042	CcSEcCtD
Alfuzosin—Dry mouth—Timolol—coronary artery disease	0.00016	0.00042	CcSEcCtD
Alfuzosin—Pain—Losartan—coronary artery disease	0.00016	0.00042	CcSEcCtD
Alfuzosin—Constipation—Losartan—coronary artery disease	0.00016	0.00042	CcSEcCtD
Alfuzosin—Syncope—Lisinopril—coronary artery disease	0.00016	0.000419	CcSEcCtD
Alfuzosin—Vomiting—Eplerenone—coronary artery disease	0.00016	0.000419	CcSEcCtD
Alfuzosin—Feeling abnormal—Furosemide—coronary artery disease	0.00016	0.000419	CcSEcCtD
Alfuzosin—Nausea—Fenofibrate—coronary artery disease	0.00016	0.000418	CcSEcCtD
Alfuzosin—Pruritus—Niacin—coronary artery disease	0.00016	0.000417	CcSEcCtD
Alfuzosin—Asthenia—Pravastatin—coronary artery disease	0.000159	0.000417	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000159	0.000416	CcSEcCtD
Alfuzosin—Rash—Eplerenone—coronary artery disease	0.000159	0.000416	CcSEcCtD
Alfuzosin—Urticaria—Perindopril—coronary artery disease	0.000159	0.000416	CcSEcCtD
Alfuzosin—Dermatitis—Eplerenone—coronary artery disease	0.000159	0.000415	CcSEcCtD
Alfuzosin—Diarrhoea—Valsartan—coronary artery disease	0.000159	0.000415	CcSEcCtD
Alfuzosin—Shock—Ramipril—coronary artery disease	0.000158	0.000414	CcSEcCtD
Alfuzosin—Abdominal pain—Perindopril—coronary artery disease	0.000158	0.000414	CcSEcCtD
Alfuzosin—Palpitations—Lisinopril—coronary artery disease	0.000158	0.000413	CcSEcCtD
Alfuzosin—Diarrhoea—Olmesartan—coronary artery disease	0.000158	0.000413	CcSEcCtD
Alfuzosin—Headache—Eplerenone—coronary artery disease	0.000158	0.000413	CcSEcCtD
Alfuzosin—Nervous system disorder—Ramipril—coronary artery disease	0.000158	0.000413	CcSEcCtD
Alfuzosin—Thrombocytopenia—Ramipril—coronary artery disease	0.000158	0.000412	CcSEcCtD
Alfuzosin—Oedema—Timolol—coronary artery disease	0.000157	0.000411	CcSEcCtD
Alfuzosin—Pruritus—Pravastatin—coronary artery disease	0.000157	0.000411	CcSEcCtD
Alfuzosin—Loss of consciousness—Lisinopril—coronary artery disease	0.000157	0.000411	CcSEcCtD
Alfuzosin—Nausea—Clopidogrel—coronary artery disease	0.000157	0.000411	CcSEcCtD
Alfuzosin—Tachycardia—Ramipril—coronary artery disease	0.000157	0.000411	CcSEcCtD
Alfuzosin—Skin disorder—Ramipril—coronary artery disease	0.000156	0.000409	CcSEcCtD
Alfuzosin—Infection—Timolol—coronary artery disease	0.000156	0.000409	CcSEcCtD
Alfuzosin—Vomiting—Simvastatin—coronary artery disease	0.000156	0.000409	CcSEcCtD
Alfuzosin—Nausea—Lovastatin—coronary artery disease	0.000156	0.000408	CcSEcCtD
Alfuzosin—Hyperhidrosis—Ramipril—coronary artery disease	0.000156	0.000407	CcSEcCtD
Alfuzosin—Rash—Simvastatin—coronary artery disease	0.000155	0.000405	CcSEcCtD
Alfuzosin—Dermatitis—Simvastatin—coronary artery disease	0.000155	0.000405	CcSEcCtD
Alfuzosin—Asthenia—Trandolapril—coronary artery disease	0.000155	0.000405	CcSEcCtD
Alfuzosin—Shock—Timolol—coronary artery disease	0.000155	0.000405	CcSEcCtD
Alfuzosin—Feeling abnormal—Losartan—coronary artery disease	0.000155	0.000404	CcSEcCtD
Alfuzosin—Urticaria—Furosemide—coronary artery disease	0.000154	0.000404	CcSEcCtD
Alfuzosin—Diarrhoea—Niacin—coronary artery disease	0.000154	0.000404	CcSEcCtD
Alfuzosin—Nervous system disorder—Timolol—coronary artery disease	0.000154	0.000403	CcSEcCtD
Alfuzosin—Asthenia—Enalapril—coronary artery disease	0.000154	0.000403	CcSEcCtD
Alfuzosin—Headache—Simvastatin—coronary artery disease	0.000154	0.000403	CcSEcCtD
Alfuzosin—Abdominal pain—Furosemide—coronary artery disease	0.000154	0.000402	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Losartan—coronary artery disease	0.000153	0.000401	CcSEcCtD
Alfuzosin—Dizziness—Valsartan—coronary artery disease	0.000153	0.000401	CcSEcCtD
Alfuzosin—Nausea—Ezetimibe—coronary artery disease	0.000153	0.0004	CcSEcCtD
Alfuzosin—Skin disorder—Timolol—coronary artery disease	0.000153	0.0004	CcSEcCtD
Alfuzosin—Dizziness—Olmesartan—coronary artery disease	0.000153	0.000399	CcSEcCtD
Alfuzosin—Pruritus—Trandolapril—coronary artery disease	0.000153	0.000399	CcSEcCtD
Alfuzosin—Arthralgia—Lisinopril—coronary artery disease	0.000152	0.000398	CcSEcCtD
Alfuzosin—Chest pain—Lisinopril—coronary artery disease	0.000152	0.000398	CcSEcCtD
Alfuzosin—Hyperhidrosis—Timolol—coronary artery disease	0.000152	0.000398	CcSEcCtD
Alfuzosin—Asthenia—Telmisartan—coronary artery disease	0.000152	0.000398	CcSEcCtD
Alfuzosin—Pruritus—Enalapril—coronary artery disease	0.000152	0.000397	CcSEcCtD
Alfuzosin—Diarrhoea—Pravastatin—coronary artery disease	0.000152	0.000397	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000151	0.000395	CcSEcCtD
Alfuzosin—Discomfort—Lisinopril—coronary artery disease	0.00015	0.000393	CcSEcCtD
Alfuzosin—Hypotension—Ramipril—coronary artery disease	0.00015	0.000393	CcSEcCtD
Alfuzosin—Pruritus—Telmisartan—coronary artery disease	0.00015	0.000392	CcSEcCtD
Alfuzosin—Nausea—Eplerenone—coronary artery disease	0.00015	0.000392	CcSEcCtD
Alfuzosin—Dizziness—Niacin—coronary artery disease	0.000149	0.00039	CcSEcCtD
Alfuzosin—Urticaria—Losartan—coronary artery disease	0.000149	0.00039	CcSEcCtD
Alfuzosin—Dry mouth—Lisinopril—coronary artery disease	0.000149	0.000389	CcSEcCtD
Alfuzosin—Abdominal pain—Losartan—coronary artery disease	0.000148	0.000388	CcSEcCtD
Alfuzosin—Asthenia—Captopril—coronary artery disease	0.000148	0.000387	CcSEcCtD
Alfuzosin—Diarrhoea—Trandolapril—coronary artery disease	0.000148	0.000386	CcSEcCtD
Alfuzosin—Vomiting—Valsartan—coronary artery disease	0.000148	0.000386	CcSEcCtD
Alfuzosin—Diarrhoea—Enalapril—coronary artery disease	0.000147	0.000384	CcSEcCtD
Alfuzosin—Hypotension—Timolol—coronary artery disease	0.000147	0.000384	CcSEcCtD
Alfuzosin—Dizziness—Pravastatin—coronary artery disease	0.000147	0.000384	CcSEcCtD
Alfuzosin—Vomiting—Olmesartan—coronary artery disease	0.000147	0.000384	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000147	0.000383	CcSEcCtD
Alfuzosin—Rash—Valsartan—coronary artery disease	0.000146	0.000383	CcSEcCtD
Alfuzosin—Dermatitis—Valsartan—coronary artery disease	0.000146	0.000382	CcSEcCtD
Alfuzosin—Nausea—Simvastatin—coronary artery disease	0.000146	0.000382	CcSEcCtD
Alfuzosin—Oedema—Lisinopril—coronary artery disease	0.000146	0.000382	CcSEcCtD
Alfuzosin—Pruritus—Captopril—coronary artery disease	0.000146	0.000381	CcSEcCtD
Alfuzosin—Rash—Olmesartan—coronary artery disease	0.000146	0.000381	CcSEcCtD
Alfuzosin—Dermatitis—Olmesartan—coronary artery disease	0.000145	0.00038	CcSEcCtD
Alfuzosin—Headache—Valsartan—coronary artery disease	0.000145	0.00038	CcSEcCtD
Alfuzosin—Diarrhoea—Telmisartan—coronary artery disease	0.000145	0.000379	CcSEcCtD
Alfuzosin—Infection—Lisinopril—coronary artery disease	0.000145	0.000379	CcSEcCtD
Alfuzosin—Headache—Olmesartan—coronary artery disease	0.000145	0.000378	CcSEcCtD
Alfuzosin—Shock—Lisinopril—coronary artery disease	0.000144	0.000375	CcSEcCtD
Alfuzosin—Asthenia—Perindopril—coronary artery disease	0.000144	0.000375	CcSEcCtD
Alfuzosin—Vomiting—Niacin—coronary artery disease	0.000143	0.000375	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000143	0.000375	CcSEcCtD
Alfuzosin—Somnolence—Ramipril—coronary artery disease	0.000143	0.000374	CcSEcCtD
Alfuzosin—Thrombocytopenia—Lisinopril—coronary artery disease	0.000143	0.000374	CcSEcCtD
Alfuzosin—Dizziness—Trandolapril—coronary artery disease	0.000143	0.000373	CcSEcCtD
Alfuzosin—Tachycardia—Lisinopril—coronary artery disease	0.000142	0.000372	CcSEcCtD
Alfuzosin—Rash—Niacin—coronary artery disease	0.000142	0.000372	CcSEcCtD
Alfuzosin—Dermatitis—Niacin—coronary artery disease	0.000142	0.000372	CcSEcCtD
Alfuzosin—Dizziness—Enalapril—coronary artery disease	0.000142	0.000372	CcSEcCtD
Alfuzosin—Skin disorder—Lisinopril—coronary artery disease	0.000142	0.000371	CcSEcCtD
Alfuzosin—Dyspepsia—Ramipril—coronary artery disease	0.000142	0.00037	CcSEcCtD
Alfuzosin—Pruritus—Perindopril—coronary artery disease	0.000142	0.00037	CcSEcCtD
Alfuzosin—Headache—Niacin—coronary artery disease	0.000141	0.00037	CcSEcCtD
Alfuzosin—Vomiting—Pravastatin—coronary artery disease	0.000141	0.000369	CcSEcCtD
Alfuzosin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000141	0.000369	CcSEcCtD
Alfuzosin—Diarrhoea—Captopril—coronary artery disease	0.000141	0.000369	CcSEcCtD
Alfuzosin—Dizziness—Telmisartan—coronary artery disease	0.00014	0.000366	CcSEcCtD
Alfuzosin—Rash—Pravastatin—coronary artery disease	0.00014	0.000366	CcSEcCtD
Alfuzosin—Dermatitis—Pravastatin—coronary artery disease	0.00014	0.000366	CcSEcCtD
Alfuzosin—Somnolence—Timolol—coronary artery disease	0.00014	0.000366	CcSEcCtD
Alfuzosin—Asthenia—Furosemide—coronary artery disease	0.00014	0.000365	CcSEcCtD
Alfuzosin—Headache—Pravastatin—coronary artery disease	0.000139	0.000364	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000139	0.000363	CcSEcCtD
Alfuzosin—Fatigue—Ramipril—coronary artery disease	0.000139	0.000363	CcSEcCtD
Alfuzosin—Dyspepsia—Timolol—coronary artery disease	0.000138	0.000362	CcSEcCtD
Alfuzosin—Nausea—Valsartan—coronary artery disease	0.000138	0.00036	CcSEcCtD
Alfuzosin—Pruritus—Furosemide—coronary artery disease	0.000138	0.00036	CcSEcCtD
Alfuzosin—Constipation—Ramipril—coronary artery disease	0.000138	0.00036	CcSEcCtD
Alfuzosin—Nausea—Olmesartan—coronary artery disease	0.000137	0.000359	CcSEcCtD
Alfuzosin—Vomiting—Trandolapril—coronary artery disease	0.000137	0.000359	CcSEcCtD
Alfuzosin—Diarrhoea—Perindopril—coronary artery disease	0.000137	0.000358	CcSEcCtD
Alfuzosin—Vomiting—Enalapril—coronary artery disease	0.000137	0.000357	CcSEcCtD
Alfuzosin—Hypotension—Lisinopril—coronary artery disease	0.000136	0.000357	CcSEcCtD
Alfuzosin—Dizziness—Captopril—coronary artery disease	0.000136	0.000356	CcSEcCtD
Alfuzosin—Rash—Trandolapril—coronary artery disease	0.000136	0.000356	CcSEcCtD
Alfuzosin—Dermatitis—Trandolapril—coronary artery disease	0.000136	0.000355	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Timolol—coronary artery disease	0.000136	0.000355	CcSEcCtD
Alfuzosin—Fatigue—Timolol—coronary artery disease	0.000136	0.000355	CcSEcCtD
Alfuzosin—Rash—Enalapril—coronary artery disease	0.000135	0.000354	CcSEcCtD
Alfuzosin—Dermatitis—Enalapril—coronary artery disease	0.000135	0.000354	CcSEcCtD
Alfuzosin—Headache—Trandolapril—coronary artery disease	0.000135	0.000353	CcSEcCtD
Alfuzosin—Vomiting—Telmisartan—coronary artery disease	0.000135	0.000352	CcSEcCtD
Alfuzosin—Asthenia—Losartan—coronary artery disease	0.000135	0.000352	CcSEcCtD
Alfuzosin—Headache—Enalapril—coronary artery disease	0.000135	0.000352	CcSEcCtD
Alfuzosin—Pain—Timolol—coronary artery disease	0.000134	0.000352	CcSEcCtD
Alfuzosin—Nausea—Niacin—coronary artery disease	0.000134	0.00035	CcSEcCtD
Alfuzosin—Rash—Telmisartan—coronary artery disease	0.000134	0.000349	CcSEcCtD
Alfuzosin—Dermatitis—Telmisartan—coronary artery disease	0.000133	0.000349	CcSEcCtD
Alfuzosin—Diarrhoea—Furosemide—coronary artery disease	0.000133	0.000348	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000133	0.000348	CcSEcCtD
Alfuzosin—Pruritus—Losartan—coronary artery disease	0.000133	0.000347	CcSEcCtD
Alfuzosin—Headache—Telmisartan—coronary artery disease	0.000133	0.000347	CcSEcCtD
Alfuzosin—Feeling abnormal—Ramipril—coronary artery disease	0.000133	0.000347	CcSEcCtD
Alfuzosin—Dizziness—Perindopril—coronary artery disease	0.000132	0.000346	CcSEcCtD
Alfuzosin—Nausea—Pravastatin—coronary artery disease	0.000132	0.000345	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000132	0.000344	CcSEcCtD
Alfuzosin—Vomiting—Captopril—coronary artery disease	0.000131	0.000343	CcSEcCtD
Alfuzosin—Rash—Captopril—coronary artery disease	0.00013	0.00034	CcSEcCtD
Alfuzosin—Dermatitis—Captopril—coronary artery disease	0.00013	0.000339	CcSEcCtD
Alfuzosin—Somnolence—Lisinopril—coronary artery disease	0.00013	0.000339	CcSEcCtD
Alfuzosin—Feeling abnormal—Timolol—coronary artery disease	0.00013	0.000339	CcSEcCtD
Alfuzosin—Headache—Captopril—coronary artery disease	0.000129	0.000338	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Timolol—coronary artery disease	0.000129	0.000336	CcSEcCtD
Alfuzosin—Dizziness—Furosemide—coronary artery disease	0.000129	0.000336	CcSEcCtD
Alfuzosin—Dyspepsia—Lisinopril—coronary artery disease	0.000128	0.000336	CcSEcCtD
Alfuzosin—Diarrhoea—Losartan—coronary artery disease	0.000128	0.000336	CcSEcCtD
Alfuzosin—Nausea—Trandolapril—coronary artery disease	0.000128	0.000335	CcSEcCtD
Alfuzosin—Urticaria—Ramipril—coronary artery disease	0.000128	0.000334	CcSEcCtD
Alfuzosin—Nausea—Enalapril—coronary artery disease	0.000128	0.000334	CcSEcCtD
Alfuzosin—Vomiting—Perindopril—coronary artery disease	0.000127	0.000333	CcSEcCtD
Alfuzosin—Abdominal pain—Ramipril—coronary artery disease	0.000127	0.000333	CcSEcCtD
Alfuzosin—Rash—Perindopril—coronary artery disease	0.000126	0.00033	CcSEcCtD
Alfuzosin—Dermatitis—Perindopril—coronary artery disease	0.000126	0.00033	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000126	0.000329	CcSEcCtD
Alfuzosin—Nausea—Telmisartan—coronary artery disease	0.000126	0.000329	CcSEcCtD
Alfuzosin—Fatigue—Lisinopril—coronary artery disease	0.000126	0.000329	CcSEcCtD
Alfuzosin—Headache—Perindopril—coronary artery disease	0.000125	0.000328	CcSEcCtD
Alfuzosin—Urticaria—Timolol—coronary artery disease	0.000125	0.000327	CcSEcCtD
Alfuzosin—Pain—Lisinopril—coronary artery disease	0.000125	0.000326	CcSEcCtD
Alfuzosin—Constipation—Lisinopril—coronary artery disease	0.000125	0.000326	CcSEcCtD
Alfuzosin—Abdominal pain—Timolol—coronary artery disease	0.000124	0.000325	CcSEcCtD
Alfuzosin—Dizziness—Losartan—coronary artery disease	0.000124	0.000325	CcSEcCtD
Alfuzosin—Vomiting—Furosemide—coronary artery disease	0.000124	0.000323	CcSEcCtD
Alfuzosin—Rash—Furosemide—coronary artery disease	0.000123	0.000321	CcSEcCtD
Alfuzosin—Dermatitis—Furosemide—coronary artery disease	0.000122	0.00032	CcSEcCtD
Alfuzosin—Nausea—Captopril—coronary artery disease	0.000122	0.00032	CcSEcCtD
Alfuzosin—Headache—Furosemide—coronary artery disease	0.000122	0.000319	CcSEcCtD
Alfuzosin—Feeling abnormal—Lisinopril—coronary artery disease	0.00012	0.000314	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000119	0.000312	CcSEcCtD
Alfuzosin—Vomiting—Losartan—coronary artery disease	0.000119	0.000312	CcSEcCtD
Alfuzosin—Nausea—Perindopril—coronary artery disease	0.000119	0.000311	CcSEcCtD
Alfuzosin—Rash—Losartan—coronary artery disease	0.000118	0.000309	CcSEcCtD
Alfuzosin—Dermatitis—Losartan—coronary artery disease	0.000118	0.000309	CcSEcCtD
Alfuzosin—Headache—Losartan—coronary artery disease	0.000118	0.000307	CcSEcCtD
Alfuzosin—Urticaria—Lisinopril—coronary artery disease	0.000116	0.000303	CcSEcCtD
Alfuzosin—Nausea—Furosemide—coronary artery disease	0.000116	0.000302	CcSEcCtD
Alfuzosin—Asthenia—Ramipril—coronary artery disease	0.000115	0.000302	CcSEcCtD
Alfuzosin—Abdominal pain—Lisinopril—coronary artery disease	0.000115	0.000302	CcSEcCtD
Alfuzosin—Pruritus—Ramipril—coronary artery disease	0.000114	0.000298	CcSEcCtD
Alfuzosin—Asthenia—Timolol—coronary artery disease	0.000113	0.000295	CcSEcCtD
Alfuzosin—Nausea—Losartan—coronary artery disease	0.000111	0.000291	CcSEcCtD
Alfuzosin—Pruritus—Timolol—coronary artery disease	0.000111	0.000291	CcSEcCtD
Alfuzosin—Diarrhoea—Ramipril—coronary artery disease	0.00011	0.000288	CcSEcCtD
Alfuzosin—Diarrhoea—Timolol—coronary artery disease	0.000108	0.000281	CcSEcCtD
Alfuzosin—Dizziness—Ramipril—coronary artery disease	0.000106	0.000278	CcSEcCtD
Alfuzosin—Asthenia—Lisinopril—coronary artery disease	0.000105	0.000274	CcSEcCtD
Alfuzosin—Dizziness—Timolol—coronary artery disease	0.000104	0.000272	CcSEcCtD
Alfuzosin—Pruritus—Lisinopril—coronary artery disease	0.000103	0.00027	CcSEcCtD
Alfuzosin—Vomiting—Ramipril—coronary artery disease	0.000102	0.000268	CcSEcCtD
Alfuzosin—Rash—Ramipril—coronary artery disease	0.000101	0.000265	CcSEcCtD
Alfuzosin—Dermatitis—Ramipril—coronary artery disease	0.000101	0.000265	CcSEcCtD
Alfuzosin—Headache—Ramipril—coronary artery disease	0.000101	0.000264	CcSEcCtD
Alfuzosin—Vomiting—Timolol—coronary artery disease	0.0001	0.000262	CcSEcCtD
Alfuzosin—Diarrhoea—Lisinopril—coronary artery disease	9.98e-05	0.000261	CcSEcCtD
Alfuzosin—Rash—Timolol—coronary artery disease	9.92e-05	0.000259	CcSEcCtD
Alfuzosin—Dermatitis—Timolol—coronary artery disease	9.91e-05	0.000259	CcSEcCtD
Alfuzosin—Headache—Timolol—coronary artery disease	9.85e-05	0.000258	CcSEcCtD
Alfuzosin—Dizziness—Lisinopril—coronary artery disease	9.65e-05	0.000252	CcSEcCtD
Alfuzosin—Nausea—Ramipril—coronary artery disease	9.56e-05	0.00025	CcSEcCtD
Alfuzosin—Nausea—Timolol—coronary artery disease	9.34e-05	0.000244	CcSEcCtD
Alfuzosin—Vomiting—Lisinopril—coronary artery disease	9.28e-05	0.000243	CcSEcCtD
Alfuzosin—Rash—Lisinopril—coronary artery disease	9.2e-05	0.000241	CcSEcCtD
Alfuzosin—Dermatitis—Lisinopril—coronary artery disease	9.19e-05	0.00024	CcSEcCtD
Alfuzosin—Headache—Lisinopril—coronary artery disease	9.14e-05	0.000239	CcSEcCtD
Alfuzosin—Nausea—Lisinopril—coronary artery disease	8.67e-05	0.000227	CcSEcCtD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—coronary artery disease	1.43e-05	9.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	1.43e-05	9.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—S100B—coronary artery disease	1.43e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PPP2CA—coronary artery disease	1.43e-05	9.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	1.42e-05	9.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCD—coronary artery disease	1.4e-05	9.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	1.4e-05	9.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	1.4e-05	9.57e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.38e-05	9.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	1.37e-05	9.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—coronary artery disease	1.37e-05	9.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	1.37e-05	9.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—C3—coronary artery disease	1.37e-05	9.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	1.37e-05	9.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	1.37e-05	9.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	1.37e-05	9.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	1.37e-05	9.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	1.36e-05	9.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.36e-05	9.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LCAT—coronary artery disease	1.36e-05	9.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	1.34e-05	9.14e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA4—coronary artery disease	1.33e-05	9.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	1.33e-05	9.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	1.33e-05	9.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLG—coronary artery disease	1.33e-05	9.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOB—coronary artery disease	1.32e-05	9.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	1.31e-05	8.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HIF1A—coronary artery disease	1.3e-05	8.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	1.3e-05	8.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGT—coronary artery disease	1.3e-05	8.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	1.3e-05	8.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	1.29e-05	8.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	1.29e-05	8.82e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.29e-05	8.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCLM—coronary artery disease	1.29e-05	8.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	1.28e-05	8.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	1.27e-05	8.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—coronary artery disease	1.27e-05	8.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—coronary artery disease	1.27e-05	8.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	1.27e-05	8.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	1.27e-05	8.69e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	1.27e-05	8.69e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—S100B—coronary artery disease	1.27e-05	8.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—coronary artery disease	1.26e-05	8.63e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—coronary artery disease	1.26e-05	8.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	1.26e-05	8.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	1.25e-05	8.55e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	1.25e-05	8.55e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KDR—coronary artery disease	1.25e-05	8.54e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.25e-05	8.52e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.25e-05	8.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	1.24e-05	8.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	1.24e-05	8.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK14—coronary artery disease	1.24e-05	8.48e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.23e-05	8.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	1.22e-05	8.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ESR1—coronary artery disease	1.22e-05	8.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	1.21e-05	8.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	1.21e-05	8.3e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HADH—coronary artery disease	1.21e-05	8.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.21e-05	8.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—coronary artery disease	1.2e-05	8.22e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FN1—coronary artery disease	1.2e-05	8.22e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6ST—coronary artery disease	1.2e-05	8.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	1.19e-05	8.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NFKBIA—coronary artery disease	1.19e-05	8.12e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	1.18e-05	8.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOB—coronary artery disease	1.17e-05	8.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	1.16e-05	7.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	1.16e-05	7.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	1.16e-05	7.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	1.15e-05	7.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KIT—coronary artery disease	1.15e-05	7.86e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA2—coronary artery disease	1.15e-05	7.85e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.15e-05	7.85e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX2—coronary artery disease	1.15e-05	7.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	1.15e-05	7.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	1.14e-05	7.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—C3—coronary artery disease	1.14e-05	7.77e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.13e-05	7.75e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HK1—coronary artery disease	1.13e-05	7.75e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX4—coronary artery disease	1.13e-05	7.75e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.13e-05	7.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	1.13e-05	7.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	1.13e-05	7.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—coronary artery disease	1.12e-05	7.66e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HADHA—coronary artery disease	1.12e-05	7.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	1.11e-05	7.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	1.11e-05	7.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.11e-05	7.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	1.1e-05	7.55e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—POMC—coronary artery disease	1.09e-05	7.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	1.09e-05	7.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPA—coronary artery disease	1.09e-05	7.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	1.08e-05	7.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	1.08e-05	7.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—coronary artery disease	1.08e-05	7.38e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	1.07e-05	7.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	1.07e-05	7.3e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.06e-05	7.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—coronary artery disease	1.06e-05	7.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—coronary artery disease	1.06e-05	7.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	1.06e-05	7.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	1.05e-05	7.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	1.05e-05	7.19e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA5—coronary artery disease	1.05e-05	7.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	1.05e-05	7.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	1.05e-05	7.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—coronary artery disease	1.04e-05	7.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	1.03e-05	7.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	1.03e-05	7.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—P4HB—coronary artery disease	1.03e-05	7.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	1.01e-05	6.91e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.01e-05	6.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	1.01e-05	6.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—C3—coronary artery disease	1.01e-05	6.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	1e-05	6.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	1e-05	6.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FN1—coronary artery disease	9.97e-06	6.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—coronary artery disease	9.97e-06	6.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	9.93e-06	6.79e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	9.85e-06	6.74e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	9.68e-06	6.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	9.62e-06	6.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—coronary artery disease	9.58e-06	6.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	9.54e-06	6.53e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KIT—coronary artery disease	9.54e-06	6.53e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—VCAN—coronary artery disease	9.52e-06	6.51e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.44e-06	6.46e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—coronary artery disease	9.39e-06	6.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—coronary artery disease	9.39e-06	6.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	9.28e-06	6.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	9.27e-06	6.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—coronary artery disease	9.2e-06	6.29e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DCN—coronary artery disease	9.17e-06	6.27e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	9.16e-06	6.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	9.14e-06	6.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	9.09e-06	6.22e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—POMC—coronary artery disease	9.08e-06	6.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	9.08e-06	6.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	8.97e-06	6.13e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.92e-06	6.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	8.89e-06	6.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	8.86e-06	6.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—coronary artery disease	8.86e-06	6.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FN1—coronary artery disease	8.86e-06	6.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	8.82e-06	6.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	8.75e-06	5.99e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	8.74e-06	5.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	8.69e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HBA1—coronary artery disease	8.69e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LIPC—coronary artery disease	8.69e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.69e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.69e-06	5.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOC3—coronary artery disease	8.64e-06	5.91e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LDLR—coronary artery disease	8.58e-06	5.87e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.48e-06	5.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.48e-06	5.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KIT—coronary artery disease	8.48e-06	5.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	8.46e-06	5.79e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCLC—coronary artery disease	8.38e-06	5.74e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CETP—coronary artery disease	8.38e-06	5.74e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	8.31e-06	5.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	8.3e-06	5.68e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SDC1—coronary artery disease	8.29e-06	5.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	8.18e-06	5.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	8.13e-06	5.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	8.1e-06	5.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—POMC—coronary artery disease	8.07e-06	5.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	8.07e-06	5.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	8.05e-06	5.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	8.03e-06	5.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	7.92e-06	5.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	7.89e-06	5.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	7.89e-06	5.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	7.87e-06	5.38e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.83e-06	5.36e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.83e-06	5.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	7.76e-06	5.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	7.72e-06	5.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	7.7e-06	5.27e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	7.66e-06	5.24e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CTGF—coronary artery disease	7.65e-06	5.23e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT2—coronary artery disease	7.58e-06	5.19e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.58e-06	5.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	7.54e-06	5.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	7.43e-06	5.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	7.38e-06	5.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	7.37e-06	5.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	7.13e-06	4.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	7.04e-06	4.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	7.03e-06	4.81e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.97e-06	4.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	6.88e-06	4.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	6.84e-06	4.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	6.79e-06	4.64e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.76e-06	4.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	6.72e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	6.7e-06	4.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	6.68e-06	4.57e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GGT1—coronary artery disease	6.55e-06	4.48e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT1—coronary artery disease	6.55e-06	4.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	6.55e-06	4.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	6.35e-06	4.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	6.31e-06	4.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	6.24e-06	4.27e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	6.19e-06	4.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	6.16e-06	4.22e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	6.03e-06	4.12e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	5.97e-06	4.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	5.93e-06	4.06e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.88e-06	4.02e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.83e-06	3.99e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	5.81e-06	3.98e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.8e-06	3.97e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAT—coronary artery disease	5.72e-06	3.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	5.71e-06	3.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	5.64e-06	3.86e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOB—coronary artery disease	5.55e-06	3.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	5.47e-06	3.75e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.4e-06	3.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	5.37e-06	3.67e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—coronary artery disease	5.3e-06	3.63e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	5.24e-06	3.58e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—coronary artery disease	5.17e-06	3.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	5.14e-06	3.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	5.07e-06	3.47e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD36—coronary artery disease	5.04e-06	3.45e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.98e-06	3.4e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.78e-06	3.27e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	4.75e-06	3.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	4.65e-06	3.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	4.56e-06	3.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—coronary artery disease	4.54e-06	3.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	4.46e-06	3.05e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—coronary artery disease	4.45e-06	3.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—coronary artery disease	4.39e-06	3.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	4.39e-06	3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	3.96e-06	2.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	3.95e-06	2.7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—coronary artery disease	3.87e-06	2.65e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—POMC—coronary artery disease	3.82e-06	2.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	3.64e-06	2.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	3.51e-06	2.4e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—coronary artery disease	3.48e-06	2.38e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—coronary artery disease	3.33e-06	2.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.23e-06	2.21e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.05e-06	2.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.87e-06	1.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—coronary artery disease	1.53e-06	1.05e-05	CbGpPWpGaD
